These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

30 related articles for article (PubMed ID: 5591570)

  • 1. The clearing-factor in obese patients.
    Rodrigues J; Povoa H; Povoa LC
    Acta Biol Med Ger; 1967; 19(2):331-2. PubMed ID: 5591570
    [No Abstract]   [Full Text] [Related]  

  • 2. Activity and tissue-specific expression of lipases and tumor-necrosis factor alpha in lean and obese cats.
    Hoenig M; McGoldrick JB; deBeer M; Demacker PN; Ferguson DC
    Domest Anim Endocrinol; 2006 May; 30(4):333-44. PubMed ID: 16219442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dexamethazone and clearing factor.
    Povoa H; Calado AN
    Acta Physiol Lat Am; 1967; 17(4):326-7. PubMed ID: 5616578
    [No Abstract]   [Full Text] [Related]  

  • 4. [Lipoprotein lipase or "clearing factor"].
    Labadie P
    Rev Prat; 1976 Sep; 26(37):2573-6. PubMed ID: 968404
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical significance of preheparin serum lipoprotein lipase mass in normocholesterolemic patients with coronary artery disease].
    Hitsumoto T; Yoshinaga K; Sakurai T; Aoyagi K; Matsumoto J; Iizuka T; Kaku M; Sugiyama Y; Kanai M; Uchi T; Noike H; Ohsawa H; Watanabe H; Shirai K
    J Cardiol; 2002 Jul; 40(1):1-9. PubMed ID: 12166243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adipose triglyceride lipase gene expression in human visceral obesity.
    Berndt J; Kralisch S; Klöting N; Ruschke K; Kern M; Fasshauer M; Schön MR; Stumvoll M; Blüher M
    Exp Clin Endocrinol Diabetes; 2008 Apr; 116(4):203-10. PubMed ID: 18072017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The regional production of lipoprotein lipase in man.
    Muir JR
    Clin Sci; 1968 Apr; 34(2):261-70. PubMed ID: 5653686
    [No Abstract]   [Full Text] [Related]  

  • 8. Cross-transfusion of lipoprotein lipase activity in dogs.
    Hallberg D
    Acta Chir Scand; 1968; 134(5):327-31. PubMed ID: 5731267
    [No Abstract]   [Full Text] [Related]  

  • 9. [Blood clearing factor in infectious hepatitis].
    Malygina-Dudarova SI; Latsinik GE
    Sov Med; 1969 Apr; 32(4):51-3. PubMed ID: 5378879
    [No Abstract]   [Full Text] [Related]  

  • 10. [The clearing factor in relation to the diagnosis and treatment of the atheromasic process].
    ANDREINI A
    G Gerontol; 1960 Aug; 8():559-63. PubMed ID: 13683414
    [No Abstract]   [Full Text] [Related]  

  • 11. Differential expression of lipoprotein lipase gene in tissues of the rat model with visceral obesity and postprandial hyperlipidemia.
    Hikita M; Bujo H; Yamazaki K; Taira K; Takahashi K; Kobayashi J; Saito Y
    Biochem Biophys Res Commun; 2000 Oct; 277(2):423-9. PubMed ID: 11032739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clearing factor in a rat's plasma after 7 days of fasting].
    Póvoa H; Callado AN
    Hospital (Rio J); 1967 Aug; 72(2):455-7. PubMed ID: 5302544
    [No Abstract]   [Full Text] [Related]  

  • 13. [Activity of the clearing factor in the pathogenesis of hyperlipidemia in experimental nephrotic syndrome].
    Nikiforova NV
    Biull Eksp Biol Med; 1966 Dec; 62(12):29-32. PubMed ID: 6005418
    [No Abstract]   [Full Text] [Related]  

  • 14. Postprandial chylomicrons and adipose tissue lipoprotein lipase are altered in type 2 diabetes independently of obesity and whole-body insulin resistance.
    Annuzzi G; Giacco R; Patti L; Di Marino L; De Natale C; Costabile G; Marra M; Santangelo C; Masella R; Rivellese AA
    Nutr Metab Cardiovasc Dis; 2008 Oct; 18(8):531-8. PubMed ID: 18321693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hematochemical findings in young workers exposed to carbon disulfide. II. The behavior of lipoproteins and the "clearing factor"].
    Visconti E; Rezman I; Maugeri U; Vidaković A; Cavalleri A
    Med Lav; 1966 Nov; 57(11):677-83. PubMed ID: 5985057
    [No Abstract]   [Full Text] [Related]  

  • 16. Different forms of obesity as a function of diet composition.
    Dourmashkin JT; Chang GQ; Gayles EC; Hill JO; Fried SK; Julien C; Leibowitz SF
    Int J Obes (Lond); 2005 Nov; 29(11):1368-78. PubMed ID: 16088331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of the intravenous administration of homologous albumin on the lipolytic enzyme activity of rabbit blood plasma].
    Soliternova IB; Nikul'cheva NG; Sanches Serrano D
    Vopr Med Khim; 1984; 30(2):87-91. PubMed ID: 6740999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Miglitol suppresses the postprandial increase in interleukin 6 and enhances active glucagon-like peptide 1 secretion in viscerally obese subjects.
    Arakawa M; Ebato C; Mita T; Fujitani Y; Shimizu T; Watada H; Kawamori R; Hirose T
    Metabolism; 2008 Sep; 57(9):1299-306. PubMed ID: 18702958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Matrix metalloproteinase-2 and -9 levels in obese patients.
    Derosa G; Ferrari I; D'Angelo A; Tinelli C; Salvadeo SA; Ciccarelli L; Piccinni MN; Gravina A; Ramondetti F; Maffioli P; Cicero AF
    Endothelium; 2008; 15(4):219-24. PubMed ID: 18663625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Lipoprotein lipase and glycoprotein of the blood].
    Vallino F; Pagliano F; Rugarli C
    G Gerontol; 1966 Nov; 14(11):1011-9. PubMed ID: 5998254
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.